CXCL12 and cancer: HSP27 was also selected due to spectral counts indicative of phosphorylation upon CXCL12 activation of CXCR4 (Figure 6A), its implications in cancer and protection from apoptosis, and the availability of a phospho-specific antibody at the Ser82 phosphorylation site [27], [28], [29].